Literature DB >> 20560393

[The i-gel, a new supraglottic airway].

Takashi Asai1, Eugene H Liu.   

Abstract

The i-gel, invented by Muhammed Aslam Nasir, is a new supraglottic airway, consisting of a mask and a tube. One notable feature of the i-gel is that the rim of the mask is designed to conform to the anatomical shape of the larynx. This enables the device to provide an airtight seal without the cuff mechanism. The mask is made of styrene ethylene butadiene styrene (SEBS), and changes its form, based on each patient's laryngeal anatomy. The tube consists of a breathing and a drain tube. It is possible to intubate the trachea through the breathing tube, and to insert a gastric tube through the drain tube. We used the i-gel in 20 adults who were breathing spontaneously under general anesthesia. In all, but one, patients, insertion was successful at the first attempt, with the mean insertion time of 12 s (range 8-25 s). It was also always possible to insert a gastric tube through the i-gel. No airway complications occurred during the anesthesia, and spontaneous breathing could be maintained. No blood was detected on the device, after uneventful removal in all the patients. We believe that the i-gel is useful in maintaining a clear airway during general anesthesia.

Entities:  

Mesh:

Year:  2010        PMID: 20560393

Source DB:  PubMed          Journal:  Masui        ISSN: 0021-4892


  3 in total

1.  Comparison of clinical performance of the I-gel with LMA proseal.

Authors:  Gaurav Chauhan; Pavan Nayar; Anita Seth; Kapil Gupta; Mamta Panwar; Nidhi Agrawal
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2013-01

2.  Use of extraglottic airways in patients undergoing ambulatory laparoscopic surgery without the need for tracheal intubation.

Authors:  T Suhitharan; Wendy H L Teoh
Journal:  Saudi J Anaesth       Date:  2013-10

3.  Comparison of the Baska and I-gel supraglottic airway devices: a randomized controlled study.

Authors:  Duygu Kara; Cafer Mutlu Sarikas
Journal:  Ann Saudi Med       Date:  2019-10-03       Impact factor: 1.526

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.